Related Experiment Video
Updated: Aug 11, 2026

An In vitro Model to Study Heterogeneity of Human Macrophage Differentiation and Polarization
Published on: June 12, 2013
Epigenetic regulation in monocyte/macrophage: A key player during atherosclerosis
Su-Jie Jia1,2, Ke-Qin Gao2, Ming Zhao1
1Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, China.
Insights
Epigenetics significantly influences atherosclerosis by regulating monocyte and macrophage functions. Understanding these epigenetic mechanisms offers new therapeutic targets for this chronic inflammatory disease.
Area of Science:
- Cardiovascular Research
- Immunology
- Epigenetics
Background:
- Atherosclerosis is a chronic inflammatory disease driven by monocyte and macrophage activity.
- The precise regulatory mechanisms governing monocyte and macrophage function in atherosclerosis remain incompletely understood.
- Epigenetic mechanisms are emerging as critical regulators in cellular processes.
Purpose of the Study:
- To review the role of epigenetic regulation in monocyte and macrophage differentiation and activation.
- To elucidate how epigenetic modifications contribute to the inflammatory processes in atherosclerosis.
- To identify potential novel therapeutic targets and biomarkers for atherosclerosis.
Main Methods:
- Literature review focusing on epigenetic mechanisms.
- Analysis of studies investigating monocyte and macrophage biology in atherosclerosis.
- Synthesis of current evidence on epigenetic regulation in cardiovascular inflammation.
Main Results:
- Epigenetic mechanisms, including DNA methylation and histone modification, play a crucial role in modulating monocyte and macrophage phenotypes.
- These epigenetic changes directly impact inflammatory responses and cellular functions relevant to atherosclerosis development.
- Evidence highlights the significant contribution of epigenetics to the pathogenesis of atherosclerosis.
Conclusions:
- Epigenetic regulation is a key factor in the development and progression of atherosclerosis.
- Targeting epigenetic pathways in monocytes and macrophages presents a promising strategy for atherosclerosis treatment.
- Further research into epigenetic biomarkers could improve atherosclerosis diagnosis and management.
Abstract:
Atherosclerosis is a chronic inflammatory disease. Recently, a growing body of evidence emphasizes that the monocyte and macrophage differentiation and activation are key processes in the development of atherosclerosis. However, the regulatory mechanism that manipulates the function of monocyte and macrophage is still unclear. Recent years, epigenetic mechanisms have received a wide attention and bring us a new field of vision. More and more evidence shows that epigenetics weighs heavily in atherosclerosis by regulating the function and differentiation states of monocyte and macrophage. In this review, we illuminate the epigenetic regulation mechanisms in monocyte and macrophage and their contributions to inflammatory processes of atherosclerosis to provide new thoughts and find novel targets or biomarkers for atherosclerosis.
More Related Videos
09:41Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
Published on: October 17, 2017
09:57Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages
Published on: August 12, 2019
Related Concept Videos
Epigenetic Regulation
Inflammation
Master Transcription Regulators
Epigenetic Regulation
X-chromosome...
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction